Watch Ticker

Minerva Neurosciences, Inc

Go to Minerva Neurosciences, Inc Website

$1.84

-0.05 (-2.78%)

Live

Previous Close

$1.8926

Day Range

$1.79 - $1.855

Previous Day Range

$1.8926 - $1.95

Market Cap

$13.4 million USD

Day Vol.

12419

Previous Day Vol.

5526

Currency

USD

Primary Exchange

Nasdaq

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight

The schizophrenia market is expected to grow significantly by 2034, driven by rising disease prevalence, expanding approved therapies, and the anticipated launch of new treatments such as Olanzapine LAI, Iclepertin, Ulotaront, and Brilaroxazine.

Related tickers: TEVA, RVPH, RVPHW, NERV.

Read Full Article

N/A - Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates - Zacks Investment Research

Cartesian Therapeutics announced positive top-line results from its mid-stage study evaluating lead candidate Descartes-08 in patients with generalized myasthenia gravis. The study achieved its primary endpoint, with 71% of MG patients treated with Descartes-08 showing significant improvements in MG Composite score compared to 25% with placebo.

Related tickers: RNAC, ARGX, ALXO, NERV.

Read Full Article

Trending Tickers

Please sign in to view